Corporate
Arrowhead's Gene Silencing Drugs Double Tirzepatide's Weight Loss, Sending Shares Surging
Jan 6
You're signed outSign in or to get full access.
AP
ARROWHEAD PHARMACEUTICALS (ARWR)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering ARROWHEAD PHARMACEUTICALS.